What is Covetrus?
Headquartered in Portland, Maine, Covetrus operates as a comprehensive technology and services provider for the companion, equine, and large-animal veterinary markets. The company distinguishes itself through an integrated ecosystem that consolidates supply chain management, prescription fulfillment, and practice management software into a unified solution. Its flagship Pulse Veterinary Operating System serves as the backbone for over 100,000 customers across 25 countries, facilitating essential functions such as scheduling, client communication, and financial invoicing. By streamlining these complex workflows, Covetrus enables veterinary professionals to focus on improving clinical outcomes while simultaneously optimizing their practice's financial performance.
The company's business model is built upon a foundation of over 60 years of industry experience, allowing it to act as a trusted partner in the modernization of veterinary care. Through the mycovetrus.com portal, the firm provides a centralized hub for ordering compounded medications and essential in-clinic supplies, effectively bridging the gap between pharmaceutical logistics and daily clinical operations.
How much funding has Covetrus raised?
Covetrus has raised a total of $4.7B across 3 funding rounds:
Debt
$250M
Private Equity
$4B
Debt
$425M
Debt (2020): $250M with participation from Clayton Dubilier & Rice LLC
Private Equity (2022): $4B led by Clayton, Dubilier & Rice and TPG
Debt (2022): $425M, investors not publicly disclosed
Key Investors in Covetrus
Clayton Dubilier & Rice LLC
A prominent private equity firm known for its focus on building stronger, more profitable businesses through operational improvements and strategic growth initiatives.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Covetrus?
With the recent influx of capital, Covetrus is well-positioned to accelerate its enterprise-level growth strategy. The company is expected to focus on deepening its software integration capabilities and expanding its footprint in international markets. As the veterinary industry continues to digitize, Covetrus's ability to provide a seamless, end-to-end operating system will likely remain a key driver of its long-term value proposition. Future strategic initiatives will likely prioritize the enhancement of its prescription services and the further automation of supply chain logistics to maintain its competitive edge in the global animal-health sector.
See full Covetrus company page
